You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
28 September 2026 - Netherlands-based holding company QIAGEN N.V. (NYSE:QGEN) (Frankfurt Prime Standard:QIA) announced on Monday that it has received US Food and Drug Administration (FDA) clearance for a new QIAstat-Dx panel, giving US laboratories a...
28 September 2026 - Radiotherapy technology company Leo Cancer Care on Sunday announced plans to further invest in the treatment experience for children undergoing radiation therapy.Following the world's first paediatric treatments using an upri...
28 September 2026 - Chinese biopharmaceutical company Innovent Biologics Inc (HKEX:01801) announced on Sunday an expansion of the global Phase 3 MarsLight-11 trial, which is evaluating IBI363 (Takeda R&D code: TAK-928) in patients with squamous n...
28 September 2026 - Chinese pharmaceutical company Akeso Inc (HK:9926) announced on Sunday that the first patient has been enrolled in COMPASSION-37 (AK104-311), a global, multicentre Phase III head-to-head trial evaluating cadonilimab, Akeso's ...
25 September 2026 - US pharmaceutical company Merck & Co Inc (NYSE:MRK), known as MSD outside the US and Canada, and its Japanese partner Eisai Co Ltd (TYO:4523) announced on Friday that the US Food and Drug Administration (FDA) has approved WELI...
25 September 2026 - Biopharmaceutical company AstraZeneca plc (STO:AZN) (LON:AZN) (NYSE:AZN) announced on Friday that the US Food and Drug Administration (FDA) has accepted and granted Priority Review to its supplemental Biologics License Application...
25 September 2026 - The University of Chicago Medicine announced on Thursday the completion of the construction phase of the AbbVie Foundation Cancer Pavilion.Scheduled to open in April 2027 on UChicago Medicine's main campus in Hyde Park on the...